$1.030
+0.042 (+4.04%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 Scienture Holdings Inc 股票吗？
TRxADE Health Inc is not a good buy right now due to its significant losses and declining performance. The current price is $0.96, which reflects a staggering year-to-date change of -72.71%. Additionally, the forward P/E ratio is 0, indicating no expected earnings growth, and the gross margin is a concerning -9.80% as of Q2 2026. The main risk is the company's negative net income, which reached -$18,363,225 in Q2 2026, highlighting ongoing financial instability.
MEDS 股价于 Wednesday 收于 $1.03，此前上涨 +4.04%
Scienture Holdings Inc (MEDS) last closed at $1.03, gaining +4.04%. These facts feed the 1-day and 1-week MEDS price prediction above.
预测驱动因素
Scienture Holdings Inc（MEDS）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bearish
MEDS 季节性分析
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。